1. World Health Organization. Regulation and Prequalification [Internet]. 2021 [cited 2021 May 16]. Available from: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance
2. Ridings JE. The thalidomide disaster, lessons from the past. Methods Mol Biol. 2013;947:575–86.
3. World Health Organization. International drug monitoring: the role of national centres. Report of a WHO meeting. [Internet]. World Heal. Organ. - Tech. Rep. Ser. 1972. Available from: https://apps.who.int/iris/bitstream/handle/10665/40968/WHO_TRS_498.pdf?sequence=1&isAllowed=y
4. Uppsala Monitoring Centre. UMC | Who we are [Internet]. [cited 2021 Jul 10]. Available from: https://www.who-umc.org/about-us/who-we-are/
5. WHO Collaborating Centre for International Drug Monitoring. About the WHO Programme for International Drug Monitoring | UMC [Internet]. 2023 [cited 2023 Feb 2]. Available from: https://who-umc.org/about-the-who-programme-for-international-drug-monitoring/